Physician profile
Erin E Mould
NPI 1265439558
$1,275.14
in general payments reported to CMS, 2019-2025
15 companies · $193 in 2025
The $193 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $271 · 2022: $317 · 2023: $45.88 · 2024: $448 · 2025: $193.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $688.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $687.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $397.42 | 2021-2025 | |
| Galderma Laboratories, L.P. | $257.53 | 2024-2025 | |
| Novo Nordisk INC | $132.29 | 2021-2023 | Wegovy |
| Bayer Healthcare Pharmaceuticals INC. | $107.93 | 2021-2023 | |
| Lilly USA, LLC | $106.61 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $68.70 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $35.87 | 2022 | |
| Novartis Pharmaceuticals Corporation | $32.30 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $25.68 | 2021 | |
| Antares Pharma, INC. | $24.00 | 2022 | |
| Bausch Health US, LLC | $23.10 | 2022 | |
| Eisai INC. | $20.45 | 2021 | |
| Boston Scientific Corporation | $14.79 | 2024 | Lux-Dx Insertable Cardiac Monitor |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.31 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.16 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Mould listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.